Free Trial

Shockwave Medical (SWAV) Stock Forecast & Price Target

$334.75
0.00 (0.00%)
(As of 05/31/2024)

Shockwave Medical - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold
Based on 11 Analyst Ratings

Consensus Price Target

$309.11
-7.66% Downside
High Forecast$368.00
Average Forecast$309.11
Low Forecast$210.00
TypeCurrent Forecast
6/16/23 to 6/15/24
1 Month Ago
5/17/23 to 5/16/24
3 Months Ago
3/18/23 to 3/17/24
1 Year Ago
6/16/22 to 6/16/23
Consensus Rating
Hold
Hold
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
6 Buy rating(s)
5 Buy rating(s)
Hold
10 Hold rating(s)
10 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$309.11$309.11$259.38$276.00
Forecasted Upside-7.66% Downside4.24% Upside13.09% Upside11.99% Upside
Get Shockwave Medical Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SWAV and its competitors with MarketBeat's FREE daily newsletter.

SWAV Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SWAV Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Shockwave Medical Stock vs. The Competition

TypeShockwave MedicalMedical CompaniesS&P 500
Consensus Rating Score
2.09
2.70
2.50
Consensus RatingHoldModerate BuyHold
Predicted Upside-7.66% Downside886.67% Upside12.22% Upside
News Sentiment RatingVery Positive News
Positive News
Positive News

Recent Analyst Forecasts and Stock Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/8/2024SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Market Perform$361.00 ➝ $335.00+2.79%
4/8/2024CL King
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Neutral
4/8/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Hold$270.00 ➝ $335.00+2.67%
4/8/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Equal Weight$285.00 ➝ $335.00+2.65%
4/5/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Kratky
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
4/5/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Hold$263.00 ➝ $335.00+2.51%
4/5/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Hold
4/5/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Peer Perform
4/2/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$290.00 ➝ $360.00+12.32%
2/16/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$200.00 ➝ $210.00-20.74%
9/29/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$218.00+6.11%
5/9/2023VNET Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
4/11/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$235.00 ➝ $275.00+21.20%
9/6/2022Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeMarket Perform ➝ Underperform$165.00-43.53%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 09:30 AM ET.

SWAV Frequently Asked Questions

What is Shockwave Medical's stock forecast and purchase recommendation?

According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Shockwave Medical is $309.11, with a high forecast of $368.00 and a low forecast of $210.00. The consensus rating for Shockwave Medical stock is Hold based on the current 10 hold ratings and 1 buy rating for SWAV. Learn more on SWAV's analyst rating history.

Do Wall Street analysts like Shockwave Medical more than its competitors?

Analysts like Shockwave Medical less than other "medical" companies. The consensus rating for Shockwave Medical is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how SWAV compares to other companies.

Is Shockwave Medical being downgraded by Wall Street analysts?

Over the previous 90 days, Shockwave Medical's stock had 1 downgrade by analysts.

Does Shockwave Medical's stock price have much upside?

According to analysts, Shockwave Medical's stock has a predicted upside of 4.24% based on their 12-month stock forecasts.

What analysts cover Shockwave Medical?

Shockwave Medical has been rated by research analysts at Canaccord Genuity Group, CL King, Deutsche Bank Aktiengesellschaft, Leerink Partnrs, Morgan Stanley, Needham & Company LLC, Piper Sandler, SVB Leerink, and Wolfe Research in the past 90 days.


Stock Forecasts and Research Tools

This page (NASDAQ:SWAV) was last updated on 6/15/2024 by MarketBeat.com Staff

From Our Partners